title: Profiles of [3H]N-[1-(2-thienyl)cyclohexyl]piperidine binding in brain synaptic membranes treated with Triton X-100.
abstract: Binding of [3H]N-[1-(2-thienyl)cyclohexyl]piperidine (TCP) was examined using rat brain synaptic membranes treated with a low concentration of Triton X-100. This compound is assumed to be a non-competitive antagonist for the N-methyl-D-aspartate(NMDA)-sensitive subclass of central excitatory amino acid receptors. Binding was quite low but detectable in Triton-treated membranes irrespective of the incubation temperature, and the temperature-dependent portion of the binding was greatly reduced in these Triton-treated membranes. However, binding was drastically potentiated by the inclusion of L-glutamate and its analogous amino acids in a concentration-dependent manner at a concentration range of 10 nM to 0.1 mM. Agonists for the NMDA-sensitive subclass also potentiated binding, with agonists for the other subclasses being ineffective. Glycine at a concentration above 10 nM was not only effective as a stimulant of potentiated binding by glutamate, but was also active in enhancing binding in the absence of added glutamate. Glycine increased both the association and dissociation rates without significantly affecting the dissociation constant. Pharmacological profiles of binding in Triton-treated membranes were not significantly different from those in untreated membranes, except for that of haloperidol. Haloperidol is proposed to be highly selective for brain sigma-receptors on the basis of a potent inhibition of sigma-receptor binding. The inhibitory potency of this sigma-ligand was markedly attenuated in the presence of both glutamate and glycine in Triton-treated membranes, as compared with that in untreated membranes. These results suggest that [3H]TCP binding in Triton-treated membranes is a useful biochemical tool to evaluate predominantly the activated state of ion channels associated with the NMDA-sensitive receptors in terms of freedom from the confounding effects of endogenous amino acids.
authors.affiliation: Department of Pharmacology, Setsunan University, Osaka, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Ogita
authors.forename: T
authors.initials: T
authors.lastname: Suzuki
authors.forename: R
authors.initials: R
authors.lastname: Enomoto
authors.forename: T
authors.initials: T
authors.lastname: Ohgaki
authors.forename: J
authors.initials: J
authors.lastname: Katagawa
authors.forename: S
authors.initials: S
authors.lastname: Uchida
authors.forename: H
authors.initials: H
authors.lastname: Meguri
authors.forename: Y
authors.initials: Y
authors.lastname: Yoneda
mesh_terms: D000818:Animals; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism*; D003902:Detergents / Q000494:pharmacology; D016291:Dizocilpine Maleate / Q000494:pharmacology; D007700:Kinetics; D017830:Octoxynol; D010622:Phencyclidine / Q000031:analogs & derivatives* / Q000378:metabolism; D011092:Polyethylene Glycols / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism*; D013570:Synaptic Membranes / Q000187:drug effects / Q000378:metabolism*; D014316:Tritium
chemical_list: D003902:Detergents; D016194:Receptors, N-Methyl-D-Aspartate; D014316:Tritium; D011092:Polyethylene Glycols; D016291:Dizocilpine Maleate; C012058:tenocyclidine; D017830:Octoxynol; D010622:Phencyclidine